摘要
目的探讨彩色多普勒超声与乳腺钼靶联合应用在乳腺癌筛查中的价值。方法选取2017年1月~2018年4月在我院进行乳腺癌检查的400例女性患者作为研究对象,所有患者均采用彩色多普勒超声与乳腺钼靶进行诊断,比较两种诊断方式单独应用和联合应用的检出率。结果单独使用彩色多普勒超声组的检出率为5.75%(23/400),与单独使用乳腺钼靶组[5.50%(22/400)]比较,差异无统计学意义(P>0.05);两种诊断方式联合使用组的检出率[9.75%(39/400)]高于单独使用彩色多普勒超声组,差异有统计学意义(P<0.05);两种诊断方式联合使用组的检出率高于单独使用乳腺钼靶组,差异有统计学意义(P<0.05)。结论乳腺癌患者的临床诊断中,彩色多普勒超声与乳腺钼靶联合诊断可显著提高检出率,在乳腺癌患者的早期诊断中具有较高的临床价值。
Objective To explore the value of color Doppler ultrasound combined with molybdenum target in breast cancer screening.Methods A total of 400 female patients who underwent breast cancer examination in our hospital from January 2017 to April 2018 were selected as research objects,all patients with color Doppler ultrasound and mammary gland molybdenum target for diagnosis,the detection rates of the two diagnostic methods applied alone and in combination were compared.Results The detection rate of the color Doppler ultrasound group alone was 5.75%(23/400),which was not statistically significant compared with the mammography group alone (5.50%[22/400])(P>0.05).The detection rate of the two diagnostic methods combined group [9.75%(39/400)]was higher than that of the color Doppler ultrasound group alone,and the difference was statistically significant (P<0.05).The detection rate of the two diagnostic methods combined group was higher than that of the mammography group alone,and the difference was statistically significant (P<0.05).Conclusion In the clinical diagnosis of breast cancer patients,the combination of color Doppler ultrasound and mammography can significantly improve the diagnostic detection rate,and has a higher clinical value in the early diagnosis of breast cancer patients.
作者
赖胜兰
LAI Sheng-lan(Yudu County Maternal and Child Health Hospital,Jiangxi Province,Yudu 342300,China)
出处
《中国当代医药》
2019年第17期45-47,共3页
China Modern Medicine
关键词
彩色多普勒超声
乳腺钼靶
乳腺癌
筛查
价值
Color Doppler ultrasound
Breast mammography
Breast cancer
Screening
Value